Cancer Research Aziza Shad  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 5596-5601, November 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koshikawa, N.
Right arrow Articles by Miyazaki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koshikawa, N.
Right arrow Articles by Miyazaki, K.
[Cancer Research 59, 5596-5601, November 1, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

Overexpression of Laminin {gamma}2 Chain Monomer in Invading Gastric Carcinoma Cells1

Naohiko Koshikawa, Kayano Moriyama, Hiroyuki Takamura, Hiroto Mizushima, Yoji Nagashima, Shunsuke Yanoma and Kaoru Miyazaki2

Division of Cell Biology, Kihara Institute for Biological Research, Yokohama City University, Yokohama 244-0813 [N. K., K. Mo., H. T., H. M., K. Mi.]; Department of Pathology, Yokohama City University School of Medicine, Yokohama 236-0004 [Y. N.]; and Clinical Research Institute, Kanagawa Cancer Center, Yokohama 241-0815 [S. Y.], Japan

Laminin (LN)-5, a heterotrimer of {alpha}3, {beta}3, and {gamma}2 chains, has been suggested to be involved in tumor cell invasion. The present immunohistochemical study investigated the distribution of the LN {gamma}2 chain in 48 different human gastric adenocarcinomas. The immunohistochemical analysis showed two distinct patterns of LN {gamma}2 chain expression: (a) extracellular deposition; and (b) cytoplasmic accumulation. The extracellular deposition of the LN {gamma}2 chain was typically observed at neoplastic basement membranes of well-differentiated adenocarcinomas. The immunoreactivity was continuous along tumor basement membranes in these tumors but was irregular and diffuse in poorly differentiated carcinomas. These tumor cells coexpressed the LN {alpha}3 and {beta}3 chains, suggesting that the LN {gamma}2 chain was deposited as the LN-5 complex. In contrast, tumor cells at the invading fronts showed strong cytoplasmic staining for the LN {gamma}2 chain without any detectable signal for the LN {alpha}3 or {beta}3 chain in both well- and poorly differentiated carcinomas. On the other hand, in vitro analysis by two-dimensional SDS-PAGE demonstrated that human gastric carcinoma cells secrete a high level of LN {gamma}2 chain monomer in addition to the LN-5 complex into culture medium. These results indicate that the LN {gamma}2 chain can be secreted as a single subunit and might be involved in tumor cell invasion.




This article has been cited by other articles:


Home page
FASEB J.Home page
M. Armanet, A. Wojtusciszyn, P. Morel, G. Parnaud, P. Rousselle, C. Sinigaglia, T. Berney, and D. Bosco
Regulated laminin-332 expression in human islets of Langerhans
FASEB J, December 1, 2009; 23(12): 4046 - 4055.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Guess, B. J. LaFleur, B. L. Weidow, and V. Quaranta
A Decreased Ratio of Laminin-332 {beta}3 to {gamma}2 Subunit mRNA is Associated with Poor Prognosis in Colon Cancer
Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1584 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
J. SZELACHOWSKA, P. DZIEGIEL, J. JELEN-KRZESZEWSKA, M. JELEN, R. TARKOWSKI, B. SPYTKOWSKA, R. MATKOWSKI, and J. KORNAFEL
Correlation of Metallothionein Expression with Clinical Progression of Cancer in the Oral Cavity
Anticancer Res, February 1, 2009; 29(2): 589 - 595.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J.-Z. Shou, N. Hu, M. Takikita, M. J. Roth, L. L. Johnson, C. Giffen, Q.-H. Wang, C. Wang, Y. Wang, H. Su, et al.
Overexpression of CDC25B and LAMC2 mRNA and Protein in Esophageal Squamous Cell Carcinomas and Premalignant Lesions in Subjects from a High-Risk Population in China
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1424 - 1435.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Koshikawa, T. Minegishi, K. Nabeshima, and M. Seiki
Development of a New Tracking Tool for the Human Monomeric Laminin-{gamma}2 Chain In vitro and In vivo
Cancer Res., January 15, 2008; 68(2): 530 - 536.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
T. Ogawa, Y. Tsubota, J. Hashimoto, Y. Kariya, and K. Miyazaki
The Short Arm of Laminin {gamma}2 Chain of Laminin-5 (Laminin-332) Binds Syndecan-1 and Regulates Cellular Adhesion and Migration by Suppressing Phosphorylation of Integrin beta4 Chain
Mol. Biol. Cell, May 1, 2007; 18(5): 1621 - 1633.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Takkunen, R. Grenman, M. Hukkanen, M. Korhonen, A. Garcia de Herreros, and I. Virtanen
Snail-dependent and -independent Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Cells
J. Histochem. Cytochem., November 1, 2006; 54(11): 1263 - 1275.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Jung, S. Bang, K. Choi, E. Kim, Y. Kim, J. Kim, J. Park, H. Koo, R. T. Moon, K. Song, et al.
TC1 (C8orf4) Enhances the Wnt/{beta}-Catenin Pathway by Relieving Antagonistic Activity of Chibby
Cancer Res., January 15, 2006; 66(2): 723 - 728.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
T. Xiao, W. Ying, L. Li, Z. Hu, Y. Ma, L. Jiao, J. Ma, Y. Cai, D. Lin, S. Guo, et al.
An Approach to Studying Lung Cancer-related Proteins in Human Blood
Mol. Cell. Proteomics, October 1, 2005; 4(10): 1480 - 1486.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. Hata, M. Miyazaki, S. Seto, E. Kadota, E. Muso, K. Takasu, A. Nakano, K. Tamai, J. Uitto, M. Nagata, et al.
Nephrotic Syndrome and Aberrant Expression of Laminin Isoforms in Glomerular Basement Membranes for an Infant With Herlitz Junctional Epidermolysis Bullosa
Pediatrics, October 1, 2005; 116(4): e601 - e607.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Nitori, Y. Ino, Y. Nakanishi, T. Yamada, K. Honda, K. Yanagihara, T. Kosuge, Y. Kanai, M. Kitajima, and S. Hirohashi
Prognostic Significance of Tissue Factor in Pancreatic Ductal Adenocarcinoma
Clin. Cancer Res., April 1, 2005; 11(7): 2531 - 2539.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Koshikawa, T. Minegishi, A. Sharabi, V. Quaranta, and M. Seiki
Membrane-type Matrix Metalloproteinase-1 (MT1-MMP) Is a Processing Enzyme for Human Laminin {gamma}2 Chain
J. Biol. Chem., January 7, 2005; 280(1): 88 - 93.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
C Lenander, U J Roblick, J K Habermann, A Ost, K Tryggvason, and G Auer
Laminin 5 {gamma}2 chain expression: a marker of early invasiveness in colorectal adenomas
Mol. Pathol., December 1, 2003; 56(6): 342 - 346.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Giannelli, E. Fransvea, C. Bergamini, F. Marinosci, and S. Antonaci
Laminin-5 Chains Are Expressed Differentially in Metastatic and Nonmetastatic Hepatocellular Carcinoma
Clin. Cancer Res., September 1, 2003; 9(10): 3684 - 3691.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Katayama, N. Sanzen, A. Funakoshi, and K. Sekiguchi
Laminin {gamma}2-Chain Fragment in the Circulation: A Prognostic Indicator of Epithelial Tumor Invasion
Cancer Res., January 1, 2003; 63(1): 222 - 229.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hirosaki, Y. Tsubota, Y. Kariya, K. Moriyama, H. Mizushima, and K. Miyazaki
Laminin-6 Is Activated by Proteolytic Processing and Regulates Cellular Adhesion and Migration Differently from Laminin-5
J. Biol. Chem., December 13, 2002; 277(51): 49287 - 49295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Niki, T. Kohno, S. Iba, Y. Moriya, Y. Takahashi, M. Saito, A. Maeshima, T. Yamada, Y. Matsuno, M. Fukayama, et al.
Frequent Co-Localization of Cox-2 and Laminin-5 {gamma}2 Chain at the Invasive Front of Early-Stage Lung Adenocarcinomas
Am. J. Pathol., March 1, 2002; 160(3): 1129 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
E. P. Kaldjian, J. E. Gretz, A. O. Anderson, Y. Shi, and S. Shaw
Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix
Int. Immunol., October 1, 2001; 13(10): 1243 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. E. B. Seftor, E. A. Seftor, N. Koshikawa, P. S. Meltzer, L. M. G. Gardner, M. Bilban, W. G. Stetler-Stevenson, V. Quaranta, and M. J. C. Hendrix
Cooperative Interactions of Laminin 5 {gamma}2 Chain, Matrix Metalloproteinase-2, and Membrane Type-1-Matrix/Metalloproteinase Are Required for Mimicry of Embryonic Vasculogenesis by Aggressive Melanoma
Cancer Res., September 1, 2001; 61(17): 6322 - 6327.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Määttä, I. Virtanen, R. Burgeson, and H. Autio–Harmainen
Comparative Analysis of the Distribution of Laminin Chains in the Basement Membranes in Some Malignant Epithelial Tumors: The {{alpha}}1 Chain of Laminin Shows a Selected Expression Pattern in Human Carcinomas
J. Histochem. Cytochem., June 1, 2001; 49(6): 711 - 726.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
H. Yamamoto, F. Itoh, S. Iku, M. Hosokawa, and K. Imai
Expression of the {{gamma}}2 Chain of Laminin-5 at the Invasive Front Is Associated with Recurrence and Poor Prognosis in Human Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., April 1, 2001; 7(4): 896 - 900.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
J. Hao, L. Jackson, R. Calaluce, K. McDaniel, B. L. Dalkin, and R. B. Nagle
Investigation into the Mechanism of the Loss of Laminin 5 ({{alpha}}3{beta}3{{gamma}}2) Expression in Prostate Cancer
Am. J. Pathol., March 1, 2001; 158(3): 1129 - 1135.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hirosaki, H. Mizushima, Y. Tsubota, K. Moriyama, and K. Miyazaki
Structural Requirement of Carboxyl-terminal Globular Domains of Laminin alpha 3 Chain for Promotion of Rapid Cell Adhesion and Migration by Laminin-5
J. Biol. Chem., July 14, 2000; 275(29): 22495 - 22502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.